Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-047392)

Filing Details

Accession Number:: 0001209191-11-047392
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-09-12 09:50:34
Reporting Period:: 2011-09-09

Filing Date:: 2011-09-12
Accepted Time:: 2011-09-12 09:50:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1375200	Nupathe Inc.	PATH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1297141	H Jane Hollingsworth	C/O Nupathe Inc., 227 Washington Street, Suite 200 Conshohocken PA 19428	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-09	20,000	$2.56	213,600	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,238	Indirect	Held by the Jane Hollingsworth 2000 Irrevocable Family Trust I
Common Stock	6,238	Indirect	Held by the Bradford Hollingsworth 2000 Irrevocable Family Trust I

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.54 to 2.57, inclusive.
The reporting person disclaims beneficial ownership of the shares held by the Jane Hollingsworth 2000 Irrevocable Family Trust I.
The reporting person disclaims beneficial ownership of the shares held by the Bradford Hollingsworth 2000 Irrevocable Family Trust I.